Sino Medical: Net Profit of 47.2863 Million Yuan in 2025, Up 3057.07% Year-over-Year

MetaMuskRat · 2026-03-25T13:20:36+00:00

People's Finance News on March 25 reported that Sino Medical(688108)disclosed its annual report on March 25, achieving operating revenue of 525 million yuan in 2025, a year-on-year increase of 14.53%; net profit attributable to parent company of 47.2863 million yuan, a year-on-year increase of 3057.07%; basic earnings per share of 0.11 yuan. During the reporting period, the company's sales volume of coronary artery barb balloon dilation catheters and hospital admission volume both increased significantly, becoming a major highlight of the company's coronary business growth.

MetaMuskRat

2026-03-25 13:20:36

People’s Financial News, March 25 — Sinocare Medical (688108) announced its annual report on March 25. By 2025, the company aims to achieve operating revenue of 525 million yuan, a year-on-year increase of 14.53%; net profit attributable to shareholders of 47.2863 million yuan, a year-on-year increase of 3057.07%; and basic earnings per share of 0.11 yuan. During the reporting period, the sales volume and hospital admissions of the company’s coronary artery microballoon dilation catheters increased significantly, becoming a major highlight of the company’s coronary artery business growth.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.